Literature DB >> 30431106

Aortic constriction induces hypertension and cardiac hypertrophy via (pro)renin receptor activation and the PLC‑β3 signaling pathway.

Junyan Wu1, Cong Zhang2, Chuanjun Liu1, Aihua Zhang1, An Li1, Jingjun Zhang3, Yanling Zhang1.   

Abstract

The (pro)renin receptor [(P)RR] serves an important role in cardiovascular complications. However, the precise mechanisms of (P)RR in the heart remain obscure. The authors hypothesized that overexpression of (P)RR would be associated with activation of the relevant signal pathway which could lead to organ injury. The aim of the present study was to test the role of cardiac (P)RR and its potential signaling pathway components including phospholipase C (PLC), protein kinase C (PKC), extracellular signal‑regulated kinase (ERK)1/2 and Raf‑1 proto‑oncogene, serine/threonine kinase (Raf‑1). Hypertension and cardiac hypertrophy were induced by partial abdominal aortic ligation in Sprague‑Dawley rats. The expression levels of cardiac (P)RR, PLC‑β3, PKC, ERK1/2 and Raf‑1 were measured following administration of the handle region peptide (HRP) and PLC‑β3 inhibitor U73122. The expression of (P)RR and PLC‑β3 significantly increased in the left ventricle (P<0.05). Levels of PKC‑α, ERK1/2 and Raf‑1 in the heart rose significantly (P<0.05). HRP and U73122 significantly decreased the levels of cardiac (P)RR and PLC‑β3. Furthermore, levels of PKC‑α, ERK1/2 and Raf‑1 were also decreased (P<0.05). Cardiac parameters, blood pressure and plasma Angiotensin (Ang) I and Ang II levels were altered significantly (P<0.05). The results demonstrated that hypertension induced by aortic restriction activated the (P)RR in the heart. This action led to hypertension and cardiac hypertrophy via the (P)RR‑PLC‑β3‑PKCERK1/2‑Raf‑1 signaling pathway. These results provide a mechanism by which elevated (P)RR levels in hypertension may contribute to the development of cardiac remodeling.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30431106     DOI: 10.3892/mmr.2018.9653

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  3 in total

1.  Cholecystokinin Expression in the Development of Myocardial Hypertrophy.

Authors:  Zhongshu Han; Sheng Bi; Yongsheng Xu; Xiaoying Dong; Lixia Mei; Hailong Lin; Xueqi Li
Journal:  Scanning       Date:  2021-08-21       Impact factor: 1.932

Review 2.  Upregulation of Phospholipase C Gene Expression Due to Norepinephrine-Induced Hypertrophic Response.

Authors:  Paramjit S Tappia; Naranjan S Dhalla
Journal:  Cells       Date:  2022-08-11       Impact factor: 7.666

3.  Hydrogen-rich saline mitigates pressure overload-induced cardiac hypertrophy and atrial fibrillation in rats via the JAK-STAT signalling pathway.

Authors:  Chufeng Wang; Zezheng Pan
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.